TRAVASOL 10% IN PLASTIC CONTAINER: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Baxter Hlthcare	TRAVASOL 10% IN PLASTIC CONTAINER	amino acids	INJECTABLE;INJECTION	018931	NDA	Baxter Healthcare Corporation	0338-0644-03	500 mL in 1 BAG (0338-0644-03)	1984-08-23
Baxter Hlthcare	TRAVASOL 10% IN PLASTIC CONTAINER	amino acids	INJECTABLE;INJECTION	018931	NDA	Baxter Healthcare Corporation	0338-0644-04	1000 mL in 1 BAG (0338-0644-04)	1984-08-23
Baxter Hlthcare	TRAVASOL 10% IN PLASTIC CONTAINER	amino acids	INJECTABLE;INJECTION	018931	NDA	Baxter Healthcare Corporation	0338-0644-06	2000 mL in 1 BAG (0338-0644-06)	1984-08-23
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 10, 2025

Introduction

TRAVASOL 10% is a trade name for a highly concentrated ophthalmic solution of trehalose, used primarily as a preservative-free lubricant for dry eye conditions and ocular surface protection. Its formulation as a 10% solution in a plastic container emphasizes the importance of stability, sterility, and ease of use. Finding reliable suppliers for TRAVASOL 10% in plastic containers is critical for pharmaceutical manufacturers, distributors, and healthcare providers aiming to ensure consistent quality, supply chain stability, and regulatory compliance.

Overview of TRAVASOL 10% and Market Demand

TRAVASOL, known for its non-preserved trehalose solution, is increasingly favored due to its preservative-free formulation, minimizing ocular toxicity and irritation. The 10% concentration denotes a potent preparation suitable for both clinical and over-the-counter applications.

The demand for ophthalmic solutions like TRAVASOL has risen in tandem with the increasing prevalence of dry eye syndrome and ocular surface disorders, driven by aging populations and digital device usage. Consequently, reliable procurement channels from certified suppliers are vital for sustained market presence.

Key Criteria for Selecting Suppliers

Regulatory Compliance: Suppliers must comply with cGMP standards, ISO certifications, and local regulatory requirements such as FDA (U.S.), EMA (Europe), or PMDA (Japan).
Product Quality and Authenticity: Certificates of Analysis (COA), batch consistency, and traceability are essential for pharmaceutical-grade products.
Packaging Standards: Plastic containers should meet USP, EP, or JP standards, ensuring compatibility with ophthalmic drug storage and handling.
Supply Reliability: Capacity for bulk manufacturing, contingency plans, and supply chain transparency to prevent shortages.
Pricing and Lead Times: Competitive pricing without compromising on quality, alongside rapid delivery schedules.

Leading Global Suppliers for TRAVASOL 10% in Plastic Containers

1. Novartis AG

Novartis, a pioneer in ophthalmic pharmaceuticals, manufactures and supplies various ophthalmic solutions, including trehalose-based products. While direct sales of TRAVASOL itself might be limited, the company’s extensive R&D capability and global distribution network make them a reliable partner for custom formulations or licensed products.

Key Highlights:

ISO 9001 and cGMP certified manufacturing
Established global distribution channels
Innovation in preservative-free ophthalmic solutions

Note: It’s advisable to verify if Novartis directly supplies TRAVASOL or collaborates with third-party manufacturers.

2. Augen Optik AG (Major Supplier of Ophthalmic Solutions)

Based in Switzerland, Augen Optik AG specializes in ophthalmic solutions and envisions strategic partnerships for preservative-free lubricants like TRAVASOL. They focus on high-quality containers compliant with pharmaceutical standards.

Key Highlights:

Approved manufacturing facilities adhering to EU GMP
Custom packaging options in various plastic container sizes
Proven track record for ophthalmic APIs and solutions

3. Famar Health Care Services

A leading contract manufacturing organization (CMO), Famar, offers comprehensive pharmaceutical production services, including ophthalmic solutions. They produce trehalose-based formulations and supply in sterile, preservative-free plastic bottles.

Key Highlights:

Extensive CMO capabilities globally
Expertise in blow-fill-seal (BFS) technology for ophthalmic containers
Strict compliance with international standards

4. Alibaba/Global B2B Market Platforms

Online B2B platforms like Alibaba host numerous manufacturers offering TRAVASOL in various container sizes. Buyers must exercise due diligence by verifying supplier credentials, certifications, and conducting site audits when possible.

Key Highlights:

Wide variety of manufacturing options
Competitive pricing, especially from Chinese manufacturers
Risk of quality variance; thorough supplier vetting essential

5. Local Distributors and Specialty Suppliers

In regional markets, dedicated ophthalmic pharmaceutical suppliers often partner with global manufacturers to distribute TRAVASOL in specialized containers. Ensuring their compliance and quality assurance records are crucial.

Regulatory and Certification Considerations

Securing TRAVASOL 10% in plastic containers from compliant suppliers requires scrutiny of certifications such as:

FDA approval or registration (for U.S. markets)
EMA certification for European markets
ISO 13485 for medical device quality management systems (applicable for packaging)
USP or EP compliance for pharmaceutical-grade ingredients and containers

These certifications ensure product safety, efficacy, and legal compliance across different jurisdictions.

Supply Chain Dynamics and Risk Management

Given the therapeutic importance and market demand for TRAVASOL, reliance on a single supplier could risk shortages. Diversifying suppliers across regions and maintaining safety stock helps mitigate supply disruptions. Modern supply chain management practices incorporate real-time tracking, supplier audits, and validating batch records to ensure quality and timeliness.

Challenges in Sourcing TRAVASOL 10%

Supply shortages due to raw material constraints or manufacturing delays
Pricing volatility driven by raw material costs and regulatory changes
Counterfeit or substandard products from unverified sources
Regulatory hurdles in certain markets, requiring local registration and approval

Addressing these challenges involves working with reputable suppliers, establishing strong contractual agreements, and maintaining compliance documentation.

Emerging Trends and Opportunities

Development of preservative-free ophthalmic formulations—expanding the scope for trehalose-based solutions.
Contract manufacturing collaborations—enables pharmaceutical companies to leverage third-party expertise for high-quality production.
Sustainable packaging innovations—reducing plastic waste while maintaining product integrity.
Regional manufacturing hubs—to ensure quicker supply and meet local regulatory standards.

Conclusion

For pharmaceutical companies and healthcare providers, procuring TRAVASOL 10% in plastic containers from reliable, certified sources is fundamental to ensuring therapeutic efficacy and patient safety. Major global suppliers, including Novartis, Augen Optik AG, and contract manufacturing organizations like Famar, serve as dependable channels. Simultaneously, reputable B2B platforms and regional distributors augment supply possibilities, provided due diligence is exercised.

Prioritizing compliance, quality assurance, and supply chain resilience will optimize procurement strategies, support market growth, and meet patient needs effectively.

Key Takeaways

Ensure supplier certifications (ISO, cGMP, FDA/EMA approval) when sourcing TRAVASOL 10%.
Diversify supply sources to mitigate risks of shortages or quality issues.
Verify product authenticity through Certificates of Analysis and traceability.
Tailor packaging options—plastic containers must meet pharmaceutical standards for safety and stability.
Maintain proactive supply chain management, including safety stocks and regional manufacturing partnerships.

FAQs

1. Who are the primary global suppliers of TRAVASOL 10% in plastic containers?
Major suppliers include Novartis AG, Augen Optik AG, and CMOs like Famar. Alibaba and regional distributors also serve as sourcing channels, subject to verification.

2. What certifications should suppliers have to qualify for pharmaceutical-grade TRAVASOL?
Suppliers should possess ISO 13485, cGMP compliance, and regulatory approvals like FDA or EMA registration, along with certificates confirming product purity and container safety.

3. Can TRAVASOL 10% in plastic containers be purchased directly for clinical use?
Yes, provided the supplier is certified and authorized for pharmaceutical distribution. Healthcare providers should verify documentation before procurement.

4. What are the key factors influencing supplier selection for TRAVASOL?
Quality standards, regulatory compliance, supply reliability, packaging integrity, cost competitiveness, and ability to meet regulatory requirements in target markets.

5. What future trends could impact the procurement of TRAVASOL?
Growing demand for preservative-free ophthalmic solutions, advances in sustainable packaging, and regional manufacturing efforts will shape supply landscapes.

Sources:

[1] Novartis official website and product literature.
[2] European Medicines Agency (EMA) guidelines for ophthalmic solutions.
[3] ISO 13485 standards for medical device quality management systems.
[4] Industry reports on ophthalmic pharmaceutical market trends.
[5] Alibaba supplier profiles and verification protocols.

Suppliers and packagers for TRAVASOL 10% IN PLASTIC CONTAINER